168 related articles for article (PubMed ID: 37160638)
1. Indirect biomarkers of blood doping: A systematic review.
Krumm B; Saugy JJ; Botrè F; Donati F; Faiss R
Drug Test Anal; 2024 Jan; 16(1):49-64. PubMed ID: 37160638
[TBL] [Abstract][Full Text] [Related]
2. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
Vernec AR
Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
[TBL] [Abstract][Full Text] [Related]
3. Biomarker monitoring in sports doping control.
Pottgiesser T; Schumacher YO
Bioanalysis; 2012 Jun; 4(10):1245-53. PubMed ID: 22651568
[TBL] [Abstract][Full Text] [Related]
4. Detection of EPO doping and blood doping: the haematological module of the Athlete Biological Passport.
Schumacher YO; Saugy M; Pottgiesser T; Robinson N
Drug Test Anal; 2012 Nov; 4(11):846-53. PubMed ID: 22374784
[TBL] [Abstract][Full Text] [Related]
5. Current strategies of blood doping detection.
Pottgiesser T; Schumacher YO
Anal Bioanal Chem; 2013 Dec; 405(30):9625-39. PubMed ID: 23934350
[TBL] [Abstract][Full Text] [Related]
6. Antidoping Science: Important Lessons From the Medical Sciences.
Simon P; Neuberger EW; Wang G; Pitsiladis YP
Curr Sports Med Rep; 2018 Oct; 17(10):326-331. PubMed ID: 30300193
[TBL] [Abstract][Full Text] [Related]
7. Detection of autologous blood transfusions in athletes: a historical perspective.
Mørkeberg J
Transfus Med Rev; 2012 Jul; 26(3):199-208. PubMed ID: 22119492
[TBL] [Abstract][Full Text] [Related]
8. Practical experience with the implementation of an athlete's biological profile in athletics, cycling, football and swimming.
Zorzoli M; Pipe A; Garnier PY; Vouillamoz M; Dvorak J
Br J Sports Med; 2014 May; 48(10):862-6. PubMed ID: 24648438
[TBL] [Abstract][Full Text] [Related]
9. Monitoring of biological markers indicative of doping: the athlete biological passport.
Saugy M; Lundby C; Robinson N
Br J Sports Med; 2014 May; 48(10):827-32. PubMed ID: 24659506
[TBL] [Abstract][Full Text] [Related]
10. Athlete biological passport: longitudinal biomarkers and statistics in the fight against doping.
Dragčević D; Pandžić Jakšić V; Jakšić O
Arh Hig Rada Toksikol; 2024 Mar; 75(1):24-31. PubMed ID: 38548376
[TBL] [Abstract][Full Text] [Related]
11. Autologous Blood Transfusion in Sports: Emerging Biomarkers.
Salamin O; De Angelis S; Tissot JD; Saugy M; Leuenberger N
Transfus Med Rev; 2016 Jul; 30(3):109-15. PubMed ID: 27260108
[TBL] [Abstract][Full Text] [Related]
12. Establishing Personalized Blood Protein Reference Ranges Using Noninvasive Microsampling and Targeted Proteomics: Implications for Antidoping Strategies.
Richard VR; Mitsa G; Eshghi A; Chaplygina D; Mohammed Y; Goodlett DR; Zahedi RP; Thevis M; Borchers CH
J Proteome Res; 2024 May; 23(5):1779-1787. PubMed ID: 38655860
[TBL] [Abstract][Full Text] [Related]
13. A forensic perspective of the AFL investigation into peptides: an antidoping investigation case study.
Harcourt PR; Marclay F; Clothier B
Br J Sports Med; 2014 May; 48(10):810-3. PubMed ID: 24642697
[TBL] [Abstract][Full Text] [Related]
14. Antidoping: From health tests to the athlete biological passport.
Saugy M; Leuenberger N
Drug Test Anal; 2020 May; 12(5):621-628. PubMed ID: 31994337
[TBL] [Abstract][Full Text] [Related]
15. Use of RNA biomarkers in the antidoping field.
Loria F; Grabherr S; Kuuranne T; Leuenberger N
Bioanalysis; 2024; 16(10):475-484. PubMed ID: 38497758
[TBL] [Abstract][Full Text] [Related]
16. The Athlete Biological Passport: How to Personalize Anti-Doping Testing across an Athlete's Career?
Robinson N; Sottas PE; Schumacher YO
Med Sport Sci; 2017; 62():107-118. PubMed ID: 28578329
[TBL] [Abstract][Full Text] [Related]
17. Impact of low-volume blood withdrawal on hematological biomarkers for the athlete biological passport.
Krumm B; Saugy JJ; Botrè F; Faiss R
Drug Test Anal; 2024 Feb; 16(2):168-173. PubMed ID: 37303297
[TBL] [Abstract][Full Text] [Related]
18. An integrative 'omics' solution to the detection of recombinant human erythropoietin and blood doping.
Pitsiladis YP; Durussel J; Rabin O
Br J Sports Med; 2014 May; 48(10):856-61. PubMed ID: 24627340
[TBL] [Abstract][Full Text] [Related]
19. Recombinant erythropoietin and analogues: a challenge for doping control.
Pascual JA; Belalcazar V; de Bolos C; Gutiérrez R; Llop E; Segura J
Ther Drug Monit; 2004 Apr; 26(2):175-9. PubMed ID: 15228161
[TBL] [Abstract][Full Text] [Related]
20. Achievements and Challenges in Anti-Doping Research.
Bowers LD; Bigard X
Med Sport Sci; 2017; 62():77-90. PubMed ID: 28571018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
